Evidence map›Paper›PMID 32448915›Full record

ArticleDiabetologia2020

Sufficient increment of sulfonylurea without reintroduction of insulin ameliorates pubertal deterioration of glycaemic control in KCNJ11 neonatal diabetes treated with long-term sulfonylurea.

Shigeru Suzuki, Tokuo Mukai, Takahide Kokumai, Akiko Furuya, Yusuke Tanahashi, Hiroshi Azuma

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Diabetologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Neonatal diabetes mellitus around the world: Update 2024.Journal of diabetes investigation · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shigeru SuzukiDepartment of Pediatrics, Asahikawa Medical University, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido, 078-8510, Japan. shige5p@asahikawa-med.ac.jp.
Tokuo MukaiDepartment of Pediatrics, Japanese Red Cross Asahikawa Hospital, Asahikawa, Hokkaido, Japan.
Takahide KokumaiDepartment of Pediatrics, Asahikawa Medical University, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido, 078-8510, Japan.
Akiko FuruyaDepartment of Pediatrics, Asahikawa Medical University, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido, 078-8510, Japan.
Yusuke TanahashiDepartment of Pediatrics, Asahikawa Medical University, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido, 078-8510, Japan.
Hiroshi AzumaDepartment of Pediatrics, Asahikawa Medical University, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido, 078-8510, Japan.

Funding

JSPS KAKENHI JP18K07867
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes MellitusGlycemic ControlHumansHypoglycemic AgentsInfantKcnj11 ChannelMaleMutationPotassium Channels, Inwardly RectifyingSulfonylurea CompoundsHypoglycemic AgentsKcnj11 ChannelPotassium Channels, Inwardly RectifyingSulfonylurea CompoundsGlibenclamideGlycaemic controlKCNJ11Neonatal diabetes mellitusPubertySulfonylurea

Identifiers

PMID32448915

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.